ARTICLE AD BOX
The Eli Lilly and Novo Nordisk logos.
Mike Blake | Tom Little | Reuters
It's a tale of two drugmakers in the red-hot obesity drug market.
Both Read Entire Article
Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026
1 month ago
26
RIGHT SIDEBAR TOP AD
Popular
Left-Handed People Are More Competitive, Says Science
6 days ago
28
RIGHT SIDEBAR BOTTOM AD
English (US) ·
About Us ·
Contact Us ·
Terms & Conditions ·
Privacy Policy ·
DMCA ·
Cookie Policy ·
Advertise With Us ·
© Primetweets 2026. All rights are reserved